Edward Pratesi is a managing director at accounting and business consulting firm UHY Advisors, N.E., LLC. He has over 30 years of professional experience as a certified public accountant, with a specialization in private company valuation and strategic consulting services.
The Pfizer restructuring will be a case study in whether corporate restructuring & innovation can co-exist or whether M&A is the more viable answer, writes Edward Pratesi.